Provider of cell-based assays and validated stable cell lines and primary cells for high-throughput and high-content screening in drug discovery targeting GPCRs, nuclear hormone receptors, neurodegenerative enzymes and ion channels. Proprietary high-content fluorescence imaging to monitor intracellular cAMP and calcium, plus custom assay development and HCS services to accelerate drug discovery.